ArticlePhysiological research2026
Cardiovascular Consequences of Late-Gestational Hypoxia in Adult Female Rat Offspring and the Effects of Maternal Ergothioneine Treatment.
Article in Physiological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prenatal hypoxia (PH) predisposes offspring to cardiovascular diseases. While maternal antioxidant treatment can normalize blood pressure (BP) in offspring, it typically requires high doses that may harm both mother and fetus. The antioxidant ergothioneine (ERG), noted for its very low toxicity, has emerged as a promising candidate. Because PH-induced changes have been primarily studied in male offspring, this study was performed to investigate the impact of maternal ERG treatment and late-gestational PH on cardiovascular outcomes in adult female rat offspring. Pregnant Wistar rats were exposed to 10.5 % O2 for 4 h on gestational days (GDs) 19 and 20. Adult offspring were implanted with telemetry sensors for continuous BP and heart rate (HR) monitoring. In a second experiment, pregnant rats received ERG (35 mg/kg/day) from GD6 until delivery, and on GD20 were exposed to 10.5 % O2 for 12 h. Cardiac and renal protein expression in adult offspring was analysed by western blot. PH offspring exhibited lower HR and BP responses to restraint stress than did controls. PH increased the low-to-high frequency ratio (a marker of sympathovagal balance; P=0.051) and the standard deviation of normal-to-normal interbeat intervals (P=0.024). Despite normal cardiovascular parameters at rest, late-gestational PH programmed subtle yet lasting changes in sympathovagal balance and impaired cardiovascular reactivity to stress in adult female offspring. ERG upregulated beta1-adrenergic receptor and endothelial nitric oxide synthase, particularly in the PH group. This selective effect highlights ERG's potential as a targeted antioxidant intervention against harmful prenatal conditions. Key words Ergothioneine " Prenatal hypoxia " Female " Cardiovascular " Telemetry.
Indexed as
Identifiers
42455069PMC13557535What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.